Michael F. Freeman
- Molecular Biology top 10%
- Pharmacology top 1%
- Organic Chemistry top 10%
- Biotechnology top 2%
- Oncology
- Co-authors
- Jörn PielMaximilian J. HelfBrandon I. MorinakaBernard JohnAgneya BhushanCraig A. TownsendAnna L. VagstadCristian Gurgui
- Topics
- Chemical Synthesis and Analysis (16 papers)Microbial Natural Products and Biosynthesis (15 papers)Peptidase Inhibition and Analysis (7 papers)
- Journals
- ScienceProceedings of the National Academy of SciencesJournal of the American Chemical Society
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Michael F. Freeman
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 896
- Pharmacology 636
- Organic Chemistry 244
- Biotechnology 224
- Oncology 160
Countries citing papers authored by Michael F. Freeman
This map shows the geographic impact of Michael F. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Freeman more than expected).
Fields of papers citing papers by Michael F. Freeman
This network shows the impact of papers produced by Michael F. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Freeman. The network helps show where Michael F. Freeman may publish in the future.
Co-authorship network of co-authors of Michael F. Freeman
This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Freeman. A scholar is included among the top collaborators of Michael F. Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Freeman. Michael F. Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 19 | |
| 4 | 4 | |
| 5 | 30 | |
| 6 | 44 | |
| 7 | 55 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 96 | |
| 11 | 101 | |
| 12 | 48 | |
| 13 | 93 | |
| 14 | 21 | |
| 15 | 264 | |
| 16 | 10 | |
| 17 | 30 | |
| 18 | 25 | |
| 19 | 31 | |
| 20 | 2 |
About Michael F. Freeman
Michael F. Freeman is a scholar working on Pharmacology, Molecular Medicine and Biotechnology, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (16 papers), Microbial Natural Products and Biosynthesis (15 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Pharmacology (636 citations), Biotechnology (224 citations) and Molecular Biology (896 citations). Michael F. Freeman has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Jörn Piel, Maximilian J. Helf, Brandon I. Morinaka, Bernard John, Agneya Bhushan, Craig A. Townsend, Anna L. Vagstad, Cristian Gurgui, Shigeki Matsunaga and Hans-Georg Sahl. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.